High affinity interaction of integrin α4β1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers

Journal of Cellular Physiology

Volumn 212, Issue 2, 2007, Pages 368-374

  Klemke, Martin ^a   Weschenfelder, Tatjana ^a   Konstandin, Mathias H ^a   Samstag, Yvonne ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; CANCER CELL CULTURE; CELL ACTIVATION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MELANOMA CELL; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

ANTIBODIES; ANTIGENS, CD18; CELL ADHESION; CELL LINE, TUMOR; CHEMOTAXIS; ENDOTHELIAL CELLS; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRIN BETA3; MELANOMA; NEOPLASM INVASIVENESS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 34347393710     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21029     Document Type: Article

References (63)

1. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ. 1992. HMEC-1: Establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99:683-690.
2. Albelda SM, Mette SA, Elder DE, Stewart R, Damjanovich L, Herlyn M, Buck CA. 1990a. Integrin distribution in malignant melanoma: Association of the beta 3 subunit with tumor progression. Cancer Res 50:6757-6764.
3. Albelda SM, Oliver PD, Romer LH, Buck CA. 1990b. EndoCAM: A novel endothelial cell-cell adhesion molecule. J Cell Biol 110:1227-1237.
4. Alon R, Feigelson S. 2002. From rolling to arrest on blood vessels: Leukocyte tap dancing on endothelial integrin ligands and chemokines at sub-second contacts. Semin Immunol 14:93-104.
5. Alon R, Kassner PD, Carr MW, Finger EB, Hemler ME, Springer TA. 1995. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol 128:1243-1253.
6. Bardin N, Frances V, Lesaule G, Horschowski N, George F, Sampol J. 1996. Identification of the S-Endo 1 endothelial-associated antigen. Biochem Biophys Res Commun 218:210-216.
7. Brigati C, Noonan DM, Albini A, Benelli R. 2002. Tumors and inflammatory infiltrates: Friends or foes? Clin Exp Metastasis 19:247-258.
8. Chan PY, Aruffo A. 1993. VLA-4 integrin mediates lymphocyte migration on the inducible endothelial cell ligand VCAM-1 and the extracellular matrix ligand fibronectin. J Biol Chem 268:24655-24664.
9. Chuluyan HE, Issekutz AC. 1993. VLA-4 integrin can mediate CD11/CD18-independent transendothelial migration of human monocytes. J Clin Invest 92:2768-2777.
10. Coussens LM, Werb Z. 2002. Inflammation and cancer. Nature 420:860-867.
11. Danen EH, Aota S, van Kraats AA, Yamada KM, Ruiter DJ, van Muijen GN. 1995. Requirement for the synergy site for cell adhesion to fibronectin depends on the activation state of integrin alpha 5 beta 1. J Biol Chem 270:21612-21618.
12. Ding Z, Xiong K, Issekutz TB. 2001. Chemokines stimulate human T lymphocyte transendothelial migration to utilize VLA-4 in addition to LFA-1. J Leukoc Biol 69:458-466.
13. Ebnet K, Kaldjian EP, Anderson AO, Shaw S. 1996. Orchestrated information transfer underlying leukocyte endothelial interactions. Annu Rev Immunol 14:155-177.
14. Engers R, Gabbert HE. 2000. Mechanisms of tumor metastasis: Cell biological aspects and clinical implications. J Cancer Res Clin Oncol 126:682-692.
15. Eum SY, Lee YW, Hennig B, Toborek M. 2004. VEGF regulates PCB 104-mediated stimulation of permeability and transmigration of breast cancer cells in human microvascular endothelial cells. Exp Cell Res 296:231-244.
16. Garbi N, Arnold B, Gordon S, Hammerling GJ, Ganss R. 2004. CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction. J Immunol 172:5861-5869.
17. Garofalo A, Chirivi RG, Foglieni C, Pigott R, Mortarini R, Martin-Padura I, Anichini A, Gearing AJ, Sanchez-Madrid F, Dejana E, et al. 1995. Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases. Cancer Res 55:414-419.
18. Gottschlich S, Ambrosch P, Cordes C, Gorogh T, Schreiber S, Hasler R. 2006. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays. Int J Oncol 29:605-613.
19. Haraldsen G, Kvale D, Lien B, Farstad IN, Brandtzaeg P. 1996. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J Immunol 156:2558-2565.
20. Hart IR, Birch M, Marshall JF. 1991. Cell adhesion receptor expression during melanoma progression and metastasis. Cancer Metastasis Rev 10:115-128.
21. Higashiyama A, Watanabe H, Okumura K, Yagita H. 1996. Involvement of tumor necrosis factor alpha and very late activation antigen 4/vascular cell adhesion molecule 1 interaction in surgical-stress-enhanced experimental metastasis. Cancer Immunol Immunother 42:231-236.
22. Hofmann UB, Westphal JR, Waas ET, Becker JC, Ruiter DJ, van Muijen GN. 2000. Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: Correlation with melanoma progression. J Invest Dermatol 115:625-632.
23. Hourihan H, Allen TD, Ager A. 1993. Lymphocyte migration across high endothelium is associated with increases in alpha 4 beta 1 integrin (VLA-4) affinity. J Cell Sci 104:1049-1059.
24. Kielbassa K, Schmitz C, Gerke V. 1998. Disruption of endothelial microfilaments selectively reduces the transendothelial migration of monocytes. Exp Cell Res 243:129-141.
25. 2+ release following monocyte adhesion is required for the transendothelial migration of monocytes. Cell Calcium 30:29-40.
26. Konstandin MH, Sester U, Klemke M, Weschenfelder T, Wabnitz GH, Samstag Y. 2006. A novel flow-cytometry-based assay for quantification of affinity and avidity changes of integrins. J Immunol Methods 310:67-77.
27. Lee YW, Kuhn H, Hennig B, Neish AS, Toborek M. 2001. IL-4-induced oxidative stress upregulates VCAM-1 gene expression in human endothelial cells. J Mol Cell Cardiol 33:83-94.
28. Lidington EA, Moyes DL, McCormack AM, Rose ML. 1999. A comparison of primary endothelial cells and endothelial cell lines for studies of immune interactions. Transpl Immunol 7:239-246.
29. Luca M, Hunt B, Bucana CD, Johnson JP, Fidler IJ, Bar-Eli M. 1993. Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Res 3:35-41.
30. Luscinskas FW, Ma S, Nusrat A, Parkos CA, Shaw SK. 2002. Leukocyte transendothelial migration: A junctional affair. Semin Immunol 14:105-113.
31. Lutzky VP, Carnevale RP, Alvarez MJ, Maffia PC, Zittermann SI, Podhajcer OL, Issekutz AC, Chuluyan HE. 2006. Platelet-endothelial cell adhesion molecule-1 (CD31) recycles and induces cell growth inhibition on human tumor cell lines. J Cell Biochem 98:1334-1350.
32. Lyck R, Reiss Y, Gerwin N, Greenwood J, Adamson P, Engelhardt B. 2003. T-cell interaction with ICAM-1/ICAM-2 double-deficient brain endothelium in vitro: The cytoplasmic tail of endothelial ICAM-1 is necessary for transendothelial migration of T cells. Blood 102:3675-3683.
33. Masumoto A, Hemler ME. 1993. Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1. J Biol Chem 268:228-234.
34. Mizejewski GJ. 1999. Role of integrins in cancer: Survey of expression patterns. Proc Soc Exp Biol Med 222:124-138.
35. Moretti S, Martini L, Berti E, Pinzi C, Giannotti B. 1993. Adhesion molecule profile and malignancy of melanocytic lesions. Melanoma Res 3:235-239.
36. Newman PJ, Berndt MC, Gorski J, White GCII, Lyman S, Paddock C, Muller WA. 1990. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247:1219-1222.
37. Nicolson GL. 1988. Organ specificity of tumor metastasis: Role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev 7:143-188.
38. Okahara H, Yagita H, Miyake K, Okumura K. 1994. Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis. Cancer Res 54:3233-3236.
39. Oppenheimer-Marks N, Davis LS, Bogue DT, Ramberg J, Lipsky PE. 1991. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J Immunol 147:2913-2921.
40. Orr FW, Wang HH, Lafrenie RM, Scherbarth S, Nance DM. 2000. Interactions between cancer cells and the endothelium in metastasis. J Pathol 190:310-329.
41. Otsuka M, Kato M, Yoshikawa T, Chen H, Brown EJ, Masuho Y, Omata M, Seki N. 2001. Differential expression of the L-plastin gene in human colorectal cancer progression and metastasis. Biochem Biophys Res Commun 289:876-881.
42. Park HJ, Lee YW, Hennig B, Toborek M. 2001. Linoleic acid-induced VCAM-1 expression in human microvascular endothelial cells is mediated by the NF-kappa B-dependent pathway. Nutr Cancer 41:126-134.
43. Petri B, Bixel MG. 2006. Molecular events during leukocyte diapedesis. FEBS J 273:4399-4407.
44. Reiss Y, Engelhardt B. 1999. T cell interaction with ICAM-1-deficient endothelium in vitro: Transendothelial migration of different T cell populations is mediated by endothelial ICAM-1 and ICAM-2. Int Immunol 11:1527-1539.
45. Saini A, Seller Z, Davies D, Marshall JF, Hart IR. 1997. Activation status and function of the VLA-4 (alpha4beta1) integrin expressed on human melanoma cell lines. Int J Cancer 73:264-270.
46. Schadendorf D, Gawlik C, Haney U, Ostmeier H, Suter L, Czarnetzki BM. 1993. Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocyte tumours. J Pathol 170:429-434.
47. Schadendorf D, Heidel J, Gawlik C, Suter L, Czarnetzki BM. 1995. Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J Natl Cancer Inst 87:366-371.
48. Schoppmann SF, Birner P, Stockl J, Kalt R, Ullrich R, Caucig C, Kriehuber E, Nagy K, Alitalo K, Kerjaschki D. 2002. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 161:947-956.
49. Seller Z, Hart IR. 2000. Investigation of signal transduction pathways involved in melanoma cell spreading. Indian J Exp Biol 38:211-221.
50. Shimaoka M, Takagi J, Springer TA. 2002. Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct 31:485-516.
51. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. 1993. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9:541-573.
52. Takagi J, Springer TA. 2002. Integrin activation and structural rearrangement. Immunol Rev 186:141-163.
53. Torisu H, Ono M, Kiryu H, Furue M, Ohmoto Y, Nakayama J, Nishioka Y, Sone S, Kuwano M. 2000. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1 alpha. Int J Cancer 85:182-188.
54. Tsung K, Dolan JP, Tsung YL, Norton JA. 2002. Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection. Cancer Res 62:5069-5075.
55. Van Muijen GN, Cornelissen LM, Jansen CF, Figdor CG, Johnson JP, Brocker EB, Ruiter DJ. 1991. Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice. Clin Exp Metastasis 9:259-272.
56. van Muijen GN, Jansen KF, Cornelissen IM, Smeets DF, Beck JL, Ruiter DJ. 1991. Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice. Int J Cancer 48:85-91.
57. Varner JA, Cheresh DA. 1996. Integrins and cancer. Curr Opin Cell Biol 8:724-730.
58. Voura EB, Ramjeesingh RA, Montgomery AM, Siu CH. 2001. Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells. Mol Biol Cell 12:2699-2710.
59. Wang HS, Hung Y, Su CH, Peng ST, Guo YJ, Lai MC, Liu CY, Hsu JW. 2005. CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1). Exp Cell Res 304:116-126.
60. Weber C, Springer TA. 1998. Interaction of very late antigen-4 with VCAM-1 supports transendothelial chemotaxis of monocytes by facilitating lateral migration. J Immunol 161:6825-6834.
61. Wong D, Prameya R, Dorovini-Zis K. 1999. In vitro adhesion and migration of T lymphocytes across monolayers of human brain microvessel endothelial cells: regulation by ICAM-1, VCAM-1, E-selectin and PECAM-1. J Neuropathol Exp Neurol 58:138-152.
62. Worthylake RA, Burridge K. 2001. Leukocyte transendothelial migration: Orchestrating the underlying molecular machinery. Curr Opin Cell Biol 13:569-577.
63. Xu Y, Swerlick RA, Sepp N, Bosse D, Ades EW, Lawley TJ. 1994. Characterization of expression and modulation of cell adhesion molecules on an immortalized human dermal microvascular endothelial cell line (HMEC-1). J Invest Dermatol 102:833-837.